Table 4 Baseline and follow-up BP measurements by subgroups.
D&E | Control | p-value for group effect at 12w | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Baseline | 12-week | Δ | p-value for interaction time*group | Baseline | 12-week | Δ | p-value for interaction time*group | |||
Age | ||||||||||
24-hour SBP | Younger | 135.7 ± 9.2 | 138.6 ± 11.5 | 2.9 | 0.179 | 134.2 ± 6.5 | 136.8 ± 12.0 | 2.6 | 0.261 | 0.822 |
Older | 133.3 ± 9.2 | 134.0 ± 8.8 | 0.7 | 0.612 | 129.5 ± 7.3 | 132.2 ± 14.3 | 2.7 | 0.781 | 0.701 | |
Office SBP | Younger | 140.8 ± 7.9 | 135.2 ± 9.0 | -5.6 | 0.435 | 142.4 ± 8.0 | 147.8 ± 18.7 | 5.4 | 0.147 | 0.039 |
Older | 142.0 ± 6.7 | 130.1 ± 11.8 | -11.9 | 0.002 | 135.5 ± 5.4 | 142.0 ± 13.9 | 6.5 | 0.112 | 0.022 | |
Sex | ||||||||||
24-hour SBP | Female | 134.8 ± 11.4 | 136.0 ± 8.9 | 1.2 | 0.557 | 129.5 ± 9.5 | 135.4 ± 12.4 | 5.9 | 0.559 | 0.793 |
Male | 134.2 ± 7.5 | 135.2 ± 10.6 | 1.0 | 0.898 | 132.7 ± 5.8 | 133.9 ± 13.9 | 1.2 | 0.431 | 0.925 | |
Office SBP | Female | 141.3 ± 7.3 | 128.8 ± 11.3 | -12.5 | 0.005 | 138.1 ± 5.0 | 152.9 ± 22.2 | 14.8 | 0.004 | < 0.001 |
Male | 141.5 ± 7.4 | 134.9 ± 10.2 | -6.6 | 0.138 | 139.2 ± 8.6 | 140.3 ± 10.3 | 1.1 | 0.546 | 0.259 | |
Baseline BP | ||||||||||
24-hour SBP | Prehypertension | 134.0 ± 7.7 | 132.5 ± 8.2 | -1.5 | 0.419 | 130.5 ± 9.0 | 135.7 ± 13.8 | 5.2 | 0.108 | 0.712 |
Grade 1 hypertension | 134.6 ± 9.7 | 137.1 ± 10.3 | 2.5 | 0.268 | 132.8 ± 4.7 | 132.6 ± 12.8 | -0.2 | 0.729 | 0.451 | |
Office SBP | Prehypertension | 135.1 ± 3.4 | 131.8 ± 4.5 | -3.3 | 0.403 | 134.2 ± 4.0 | 143.9 ± 22.0 | 9.7 | 0.011 | 0.052 |
Grade 1 hypertension | 143.6 ± 6.9 | 132.2 ± 12.9 | -11.4 | 0.002 | 144.4 ± 7.0 | 145.4 ± 8.0 | 1.0 | 0.598 | 0.014 | |
